CVD Data to be Standardized Across Europe

Budgets are becoming tighter and health systems are under pressure to address the increasing burden of chronic diseases. Tackling chronic diseases requires up to date information on disease prevalence and risk factors but Europe currently lacks data on cardiovascular disease (CVD) that is standardized and can be compared.

The European Society of Cardiology (ESC) is therefore creating a task force on CVD data standardization so that data from different registries can be compared. The ESC will also collaborate with the PAtient REgistries iNiTiative (PARENT) Joint Action (1) to create an inventory of registries - this will help the cardiology community find existing data and avoid duplication.

The moves follow a meeting of cardiology organizations and experts initiated by the ESC in Brussels, Belgium, to discuss the need for coordination and standardization of CVD data in Europe (2).

The ESC task force on CVD data standardization will build on Cardiology Audit and Registration Data Standards (CARDS). ESC experts were instrumental in CARDS, which was an initiative of the Irish Ministry of Health & Children and co-funded by the European Union (EU) in 2004. CARDS aimed to standardize the definitions used in the collection of CVD data, and resulted in three data sets for three sub-specialties of cardiology: percutaneous coronary intervention, clinical electrophysiology and acute coronary syndromes.

Professor Frans Van de Werf (Leuven, Belgium), who was the instigator of the Brussels workshop, said: "CARDS is nearly 10 years old and should be updated. We need to get more countries and studies involved in implementing it so that everyone can benefit from standardized, comparable data on cardiovascular disease."

Professor Van de Werf said: "The inventory of registries will provide a single entry point for health professionals, researchers and policy makers looking for real life data on cardiovascular diseases. It will also avoid duplication of data collection in Europe. Countries will be able to use country-level data from European registries, rather than establishing their own registry. This will save valuable time and money."

1. Joint Actions are projects carried out by the European Union (EU) and one or more Member States or by the EU and the competent authorities of other countries participating in the health programme.
The PARENT Joint Action was established to support cross-border use of patient registry data for public health and research purposes including health technology assessment, pricing, and vigilance and safety. It brings support to EU member states for the development and governance of patient registries.

2. The meeting was attended by:
British Heart Foundation Health Promotion Research Group (BHFHPRG), University of Oxford (UK)
European Commission, DG SANCO (Belgium)
European Heart Network (Belgium)
European Organisation for Research & Treatment of Cancer (Belgium)
European Organisation for Research and Treatment of Cancer (EORTC) (Belgium)
European Society of Cardiology (France)
National Institute for Health & Welfare (Finland)
National Institute of Public Health (Slovenia)
Organisation for Economic Co-operation and Development (OECD)
Universities of Ghent and Brussels (Belgium)

About the European Society of Cardiology
The European Society of Cardiology (ESC) represents 80,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...